Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert M Lafrenie

Showing results (1-10 of 32) with videos related to

Pageof 4
Sort By:
Current Pharmaceutical Design|August 22, 2006
Adhesion dependent signalling in the tumour microenvironment: the future of drug targettingMary A Bewick, Robert M Lafrenie
Carcinogenesis|July 16, 2002
Role of Raf-1 and FAK in cell density-dependent regulation of integrin-dependent activation of MAP kinaseLianfeng Zhang, Mary Bewick, Robert M Lafrenie
Laboratory Investigation; a Journal of Technical Methods and Pathology|January 18, 2002
EGFR and ErbB2 differentially regulate Raf-1 translocation and activationLianfeng Zhang, Mary Bewick, Robert M Lafrenie
Journal of Radiological Protection : Official Journal of the Society for Radiological Protection|February 25, 2016
Non-targeted effects and radiation-induced carcinogenesis: a reviewJulie J Burtt, Patsy A Thompson, Robert M Lafrenie
Journal of Cellular Physiology|November 3, 2004
HSG cells differentiated by culture on extracellular matrix involves induction of S-adenosylmethione decarboxylase and ornithine decarboxylaseKirby Lam, Lianfeng Zhang, Mary Bewick, et al.
Expert Opinion on Therapeutic Targets|May 17, 2007
Cell adhesion and cancer: is there a potential for therapeutic intervention?Robert M Lafrenie, Carly A Buckner, Mary A Bewick
Journal of Cancer Research and Clinical Oncology|May 29, 2010
Nucleotide excision repair polymorphisms and survival outcome for patients with metastatic breast cancerMary A Bewick, Robert M Lafrenie, Michael S C Conlon
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 23, 2006
Polymorphisms in XRCC1, XRCC3, and CCND1 and survival after treatment for metastatic breast cancerMary A Bewick, Michael S C Conlon, Robert M Lafrenie
The Journal of Antimicrobial Chemotherapy|February 18, 2010
Attenuation of Pseudomonas aeruginosa virulence factors and biofilms by co-encapsulation of bismuth-ethanedithiol with tobramycin in liposomesMisagh Alipour, Zacharias E Suntres, Robert M Lafrenie, et al.
Breast Cancer Research and Treatment|October 9, 2007
Polymorphisms in manganese superoxide dismutase, myeloperoxidase and glutathione-S-transferase and survival after treatment for metastatic breast cancerMary A Bewick, Michael S C Conlon, Robert M Lafrenie
Pageof 4

Showing results (1-10 of 32) with videos related to

Sort By:
Pageof 4
Current Pharmaceutical Design|August 22, 2006
Adhesion dependent signalling in the tumour microenvironment: the future of drug targettingMary A Bewick, Robert M Lafrenie
Carcinogenesis|July 16, 2002
Role of Raf-1 and FAK in cell density-dependent regulation of integrin-dependent activation of MAP kinaseLianfeng Zhang, Mary Bewick, Robert M Lafrenie
Laboratory Investigation; a Journal of Technical Methods and Pathology|January 18, 2002
EGFR and ErbB2 differentially regulate Raf-1 translocation and activationLianfeng Zhang, Mary Bewick, Robert M Lafrenie
Journal of Radiological Protection : Official Journal of the Society for Radiological Protection|February 25, 2016
Non-targeted effects and radiation-induced carcinogenesis: a reviewJulie J Burtt, Patsy A Thompson, Robert M Lafrenie
Journal of Cellular Physiology|November 3, 2004
HSG cells differentiated by culture on extracellular matrix involves induction of S-adenosylmethione decarboxylase and ornithine decarboxylaseKirby Lam, Lianfeng Zhang, Mary Bewick, et al.
Expert Opinion on Therapeutic Targets|May 17, 2007
Cell adhesion and cancer: is there a potential for therapeutic intervention?Robert M Lafrenie, Carly A Buckner, Mary A Bewick
Journal of Cancer Research and Clinical Oncology|May 29, 2010
Nucleotide excision repair polymorphisms and survival outcome for patients with metastatic breast cancerMary A Bewick, Robert M Lafrenie, Michael S C Conlon
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 23, 2006
Polymorphisms in XRCC1, XRCC3, and CCND1 and survival after treatment for metastatic breast cancerMary A Bewick, Michael S C Conlon, Robert M Lafrenie
The Journal of Antimicrobial Chemotherapy|February 18, 2010
Attenuation of Pseudomonas aeruginosa virulence factors and biofilms by co-encapsulation of bismuth-ethanedithiol with tobramycin in liposomesMisagh Alipour, Zacharias E Suntres, Robert M Lafrenie, et al.
Breast Cancer Research and Treatment|October 9, 2007
Polymorphisms in manganese superoxide dismutase, myeloperoxidase and glutathione-S-transferase and survival after treatment for metastatic breast cancerMary A Bewick, Michael S C Conlon, Robert M Lafrenie
Pageof 4